Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Quest Diagnostics Incorporated
DGX
$231.14
Name : Quest Diagnostics Incorporated
Sector : Healthcare
Industry: Diagnostics & Research
Mark. Cap: $25,511,698,432.00
EPSttm : 9.42
finviz dynamic chart for DGX
Quest Diagnostics Incorporated
$231.14
1.83%
$4.32
DGX — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

3.02

Margin Of Safety %

13

Put/Call OI Ratio

0.68

EPS Next Q Diff

-0.44

EPS Last/This Y

2.32

EPS This/Next Y

0.87

Price

231.09

Target Price

249.79

Analyst Recom

2.2

Performance Q

13.42

Upside

-10.2%

Beta

0.54

Ticker: DGX




21 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-08-12DGX237.940.780.0813646
2026-08-13DGX236.180.762.7314020
2026-08-14DGX234.350.760.1014037
2026-08-17DGX235.650.770.6614020
2026-08-18DGX236.260.770.2114062
2026-08-19DGX241.770.770.6114065
2026-08-20DGX241.240.760.1414236
2026-08-21DGX244.340.711.2014671
2026-08-24DGX243.920.325.706321
2026-08-25DGX244.470.411.316761
2026-08-26DGX245.010.420.366811
2026-08-27DGX244.560.420.016859
2026-08-28DGX242.820.401.157020
2026-08-31DGX240.290.390.237141
2026-09-01DGX236.240.380.347160
2026-09-02DGX240.80.380.117235
2026-09-03DGX239.290.3715.597290
2026-09-04DGX237.020.4213.367542
2026-09-08DGX235.470.598.848479
2026-09-09DGX235.490.648.978722
2026-09-10DGX231.190.688.978975
DateSymbolLatestP/C OIP/C VolTotal OI
21 items Current Page1 of 1




20 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-08-13DGX236.0110.117.711.19
2026-08-14DGX234.2210.117.211.19
2026-08-17DGX235.5110.134.511.19
2026-08-18DGX236.2410.132.311.19
2026-08-19DGX241.7410.160.411.19
2026-08-20DGX241.3510.125.611.19
2026-08-21DGX244.6910.142.311.19
2026-08-24DGX243.8710.125.011.19
2026-08-25DGX244.5510.131.911.19
2026-08-26DGX245.0210.130.911.19
2026-08-27DGX244.6010.125.711.19
2026-08-28DGX242.9310.118.311.19
2026-08-31DGX240.4010.114.411.19
2026-09-01DGX236.2210.14.211.19
2026-09-02DGX240.7610.1249.811.19
2026-09-03DGX239.2310.1209.811.19
2026-09-04DGX236.9910.1204.511.19
2026-09-08DGX235.5310.1209.411.19
2026-09-09DGX235.7410.1221.511.19
2026-09-10DGX231.0910.1191.211.19
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
20 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-08-12DGX-13.34-1.053.35
2026-08-13DGX-12.53-1.053.35
2026-08-14DGX-12.53-1.053.35
2026-08-17DGX-12.53-0.523.35
2026-08-18DGX-8.42-0.523.35
2026-08-19DGX-8.42-0.523.35
2026-08-20DGX-8.42-0.523.35
2026-08-21DGX-7.88-0.523.35
2026-08-24DGX-7.880.943.35
2026-08-25DGX-7.880.943.35
2026-08-26DGX-7.880.943.02
2026-08-27DGX-7.880.943.02
2026-08-28DGX-7.880.943.02
2026-08-31DGX-7.880.913.02
2026-09-01DGX-11.300.913.02
2026-09-02DGX-11.300.913.02
2026-09-03DGX-11.300.913.02
2026-09-04DGX-12.730.913.02
2026-09-08DGX-8.840.933.02
2026-09-09DGX-9.000.933.02
2026-09-10DGX-9.000.933.02
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS

3.12

Avg. EPS Est. Current Quarter

2.86

Avg. EPS Est. Next Quarter

2.68

Insider Transactions

-9

Institutional Transactions

0.93

Beta

0.54

Average Sales Estimate Current Quarter

3045

Average Sales Estimate Next Quarter

3010

Fair Value

260.89

Quality Score

75

Growth Score

83

Sentiment Score

75

Actual DrawDown %

6.5

Max Drawdown 5-Year %

-28.6

Target Price

249.79

P/E

24.52

Forward P/E

19.17

PEG

1.92

P/S

2.21

P/B

3.38

P/Free Cash Flow

18.91

EPS

9.43

Average EPS Est. Cur. Y​

11.19

EPS Next Y. (Est.)

12.06

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

9.15

Relative Volume

1.13

Return on Equity vs Sector %

-11.8

Return on Equity vs Industry %

2.6

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

191.2
DGX Healthcare
$231.13
📉
Swing / Pullback
Buy the dip on strong trends
N/A
0 /100
WEAK
Trend
2/20
Pullback
16/25
Volume
4/15
Valuation
11/20
TP/AR
5/10
Options
4/10
RSI
41.3
Range 1M
9.7%
🚀
Momentum Growth
Ride accelerating trends
N/A
42 /100
WEAK
Momentum
5/25
Growth
13/30
Estimates
11/20
Inst/Vol
8/15
Options
5/10
EPS Yr
13.6%
EPS NY
7.7%
52W%
77.9%
💎
Long-Term Value
Quality companies, undervalued
35 /100
WEAK
🟡 HOLD +12.9% upside
Quality
7/30
Valuation
8/30
Growth
14/25
Stability
6/10
LT Trend
0/5
Upside
+12.9%
Quality
75
MoS
13%
DGX — P/E HistoricalDiagnostics & Research
Quest Diagnostics Incorporated
Sector: Healthcare
Industry: Diagnostics & Research
Employees: 46000
Quest Diagnostics Incorporated provides diagnostic testing and services in the United States. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides services under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers commercial clinical laboratories, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. In addition, the company offers risk assessment services for the life insurance industry; healthcare IT healthcare providers and payers; testing and medical director services at hospital laboratories; test offerings in cardiometabolic and endocrine; cancer; clinical drug monitoring and toxicology; infectious disease, including autoimmune; neurology diagnostics, including Alzheimer's disease; and women's health, such as prenatal genetic; workplace drug testing, testing urine, hair, and oral fluid specimens services; and employer population health services, including biometric screenings, flu shots, and related preventative services. Further, it provides population health solutions; extended care services; develops in vitro diagnostic tests; laboratory diagnostic information and digital health connectivity systems; underwriting support services, including data gathering, paramedical examinations, and clinical laboratory testing and analytics; and national specimen collection and health data solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.
DGX

Latest News

Caricamento notizie per DGX
stock quote shares DGX – Quest Diagnostics Incorporated Stock Price stock today
news today DGX – Quest Diagnostics Incorporated stock forecast ,stock prediction 2023 2024 2025
marketwatch DGX – Quest Diagnostics Incorporated yahoo finance google finance
stock history DGX – Quest Diagnostics Incorporated invest stock market
stock prices DGX premarket after hours
ticker DGX fair value insiders trading